{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:41:53Z","timestamp":1792021313875,"version":"4.4.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    This study utilized multiple 2-sample Mendelian randomization (MR) approaches to evaluate the causal effects of gut microbiota on the risk of constipation and Parkinson disease (PD) and further investigated the mediating role of gut microbiota in the pathway linking PD to constipation. Two-sample MR analysis was conducted to identify gut microbiota with significant causal associations with constipation. These identified gut microbiota, along with PD, were incorporated as exposure variables into a MVMR framework. A comprehensive model encompassing gut microbiota, PD, and constipation was then established to perform mediation analysis, aiming to quantify the indirect effect of PD on constipation through gut microbiota. The 2-sample MR analysis identified statistically significant causal associations (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05) between specific gut microbiota and the development of constipation. Notable findings included\n                    <jats:italic toggle=\"yes\">c_Betaproteobacteria<\/jats:italic>\n                    (OR\u2005=\u20050.899188),\n                    <jats:italic toggle=\"yes\">c_Methanobacteria<\/jats:italic>\n                    (OR\u2005=\u20050.950024),\n                    <jats:italic toggle=\"yes\">f_Methanobacteriaceae<\/jats:italic>\n                    (OR\u2005=\u20050.950024),\n                    <jats:italic toggle=\"yes\">g_Eubacterium rectale group<\/jats:italic>\n                    (OR\u2005=\u20050.893372), and\n                    <jats:italic toggle=\"yes\">o_Methanobacteriales<\/jats:italic>\n                    (OR\u2005=\u20050.950024). In the MVMR analysis, the association between PD and constipation was significant in Models 1 and 5 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). Mediation effect analysis revealed that the\n                    <jats:italic toggle=\"yes\">Eubacterium rectale group (g_Eubacterium rectale group<\/jats:italic>\n                    ) and\n                    <jats:italic toggle=\"yes\">Methanobacteriales (o_Methanobacteriales<\/jats:italic>\n                    ) exerted an indirect influence on the development of constipation through PD, with mediation effect proportions of 193.17% and 128.44%. This study revealed the potential causal effects of specific gut microbiota on constipation and, for the first time, proposed a mediating mechanism whereby PD indirectly influences constipation through certain gut microbiota. These findings provide novel insights into the complex relationships among PD, gut microbiota, and constipation, offering potential targets for gut microbiota-based interventions to address PD-associated constipation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000045552","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:00:23Z","timestamp":1763571623000},"page":"e45552","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Causal association between Parkinson disease, gut microbiota, and constipation: A Mendelian study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3655-543X","authenticated-orcid":false,"given":"Jiamu","family":"Zheng","sequence":"first","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People\u2019s Hospital, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Research Laboratory Center, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People\u2019s Hospital, Wenzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Research Laboratory Center, Wenzhou Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou People\u2019s Hospital, Wenzhou, Zhejiang, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260520","first-page":"337","article-title":"Parkinson\u2019s disease.","volume":"103","author":"Reich","year":"2019","journal-title":"Med Clin North Am"},{"key":"R2-20260520","first-page":"183","article-title":"FECOM: a new artificial stool for evaluating defecation.","volume":"94","author":"Pelsang","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R2-20260520"},{"key":"R3-20260520","first-page":"2340","article-title":"Chronic constipation.","volume":"94","author":"Bharucha","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R4-20260520","first-page":"575","article-title":"Haemorrhoids, rectal prolapse, anal fissure, peri-anal fistulae and sexually transmitted diseases.","volume":"23","author":"Felt-Bersma","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R5-20260520","first-page":"1867","article-title":"Chronic constipation as a risk factor for colorectal cancer: results from a nationwide, case-control study.","volume":"20","author":"Staller","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R6-20260520","first-page":"114","article-title":"Constipation and risk of death and cardiovascular events.","volume":"281","author":"Sumida","year":"2019","journal-title":"Atherosclerosis"},{"key":"R7-20260520","first-page":"484","article-title":"Mechanisms of action of probiotics and the gastrointestinal microbiota on gut motility and constipation.","volume":"8","author":"Dimidi","year":"2017","journal-title":"Adv Nutr (Bethesda, Md.)"},{"key":"R8-20260520","first-page":"45","article-title":"Early constipation predicts faster dementia onset in Parkinson\u2019s disease.","volume":"7","author":"Camacho","year":"2021","journal-title":"NPJ Park Dis"},{"key":"R9-20260520","first-page":"789","article-title":"Autonomic failure. depression and anxiety in Parkinson\u2019s disease.","volume":"166","author":"Berrios","year":"1995","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"R10-20260520","first-page":"567","article-title":"Parkinson disease with constipation: clinical features and relevant factors.","volume":"8","author":"Yu","year":"2018","journal-title":"Sci Rep"},{"key":"R11-20260520","first-page":"34","article-title":"Constipation in Parkinson\u2019s disease: a systematic review and meta-analysis.","volume":"86","author":"Yao","year":"2023","journal-title":"Eur Neurol"},{"key":"R12-20260520","first-page":"861035","article-title":"The pathological mechanism between the intestine and brain in the early stage of Parkinson's disease.","volume":"14","author":"Yang","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R13-20260520","first-page":"6737","article-title":"The link between the gut microbiome, inflammation, and Parkinson\u2019s disease.","volume":"107","author":"Nie","year":"2023","journal-title":"Appl Microbiol Biotechnol"},{"key":"R14-20260520","first-page":"53","article-title":"Dysbiosis of gut microbiota and microbial metabolites in Parkinson\u2019s Disease.","volume":"45","author":"Sun","year":"2018","journal-title":"Ageing Res Rev"},{"key":"R15-20260520","first-page":"643","article-title":"Treatment of psychosis in Parkinson\u2019s disease: safety considerations.","volume":"26","author":"Fernandez","year":"2003","journal-title":"Drug Saf"},{"key":"R16-20260520","first-page":"493","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s Disease.","volume":"10","author":"Skj\u00e6rb\u00e6k","year":"2021","journal-title":"J Clin Med"},{"key":"R17-20260520","first-page":"1877","article-title":"The microbiota-gut-brain axis.","volume":"99","author":"Cryan","year":"2019","journal-title":"Physiol Rev"},{"key":"R18-20260520","first-page":"330","article-title":"Recent developments in mendelian randomization studies.","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"R19-20260520","first-page":"1133","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"R20-20260520","first-page":"1614","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR Statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R21-20260520","first-page":"156","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition.","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"R22-20260520","first-page":"740","article-title":"Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants.","volume":"40","author":"Pierce","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R23-20260520","first-page":"728","article-title":"Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption.","volume":"48","author":"Bowden","year":"2019","journal-title":"Int J Epidemiol"},{"key":"R24-20260520","first-page":"377","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R25-20260520","first-page":"e1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data.","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"R26-20260520","first-page":"104700","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: Implications for pathophysiology, diagnosis, and treatment.","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol Dis"},{"key":"R27-20260520","first-page":"673","article-title":"Parkinson disease and the gut: new insights into pathogenesis and clinical relevance.","volume":"17","author":"Travagli","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R28-20260520","first-page":"2501","article-title":"Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives.","volume":"14","author":"Huang","year":"2023","journal-title":"Nat Commun"},{"key":"R29-20260520","first-page":"112444","article-title":"Association between increased and decreased gut microbiota abundance and Parkinson\u2019s disease: a systematic review and subgroup meta-analysis.","volume":"191","author":"Bai","year":"2024","journal-title":"Exp Gerontol"},{"key":"R30-20260520","first-page":"350","article-title":"Gut microbiota are related to Parkinson's disease and clinical phenotype.","volume":"30","author":"Scheperjans","year":"2014","journal-title":"Mov Disord"},{"key":"R31-20260520","first-page":"461","article-title":"The role of short-chain fatty acids in microbiota-gut-brain communication.","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R32-20260520","first-page":"428","article-title":"The influence of the gut microbiome on host metabolism through the regulation of gut hormone release.","volume":"10","author":"Martin","year":"2019","journal-title":"Front Physiol"},{"issue":"Pt B","key":"R33-20260520","first-page":"128","article-title":"Neurotransmitter modulation by the gut microbiota.","volume":"1693","author":"Strandwitz","year":"2018","journal-title":"Brain Res"},{"key":"R34-20260520","first-page":"411","article-title":"\u03b3-Aminobutyric acid production by culturable bacteria from the human intestine.","volume":"113","author":"Barrett","year":"2012","journal-title":"J Appl Microbiol"},{"key":"R35-20260520","first-page":"79","article-title":"Chronic Treatment with the probiotics lacticaseibacillus rhamnosus GG and Bifidobacterium lactis BB12 attenuates motor impairment, striatal microglial activation, and dopaminergic loss in rats with 6-hydroxydopamine-induced hemiparkinsonism.","volume":"507","author":"Cuevas-Carbonell","year":"2022","journal-title":"Neuroscience"},{"key":"R36-20260520","first-page":"21192","article-title":"A mathematical model of bacteroides thetaiotaomicron, methanobrevibacter smithii, and eubacterium rectale interactions in the human gut.","volume":"13","author":"Adrian","year":"2023","journal-title":"Sci Rep"},{"key":"R37-20260520","first-page":"1117905","article-title":"Enteric nervous system damage caused by abnormal intestinal butyrate metabolism may lead to functional constipation.","volume":"14","author":"Wang","year":"2023","journal-title":"Front Microbiol"},{"key":"R38-20260520","first-page":"625","article-title":"Pathogenesis of Parkinson disease--the gut-brain axis and environmental factors.","volume":"11","author":"Klingelhoefer","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"R39-20260520","first-page":"2099","article-title":"Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders.","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"issue":"Suppl 2","key":"R40-20260520","first-page":"28","article-title":"Parkinson\u2019s disease and gut microbiota.","volume":"77","author":"Hirayama","year":"2021","journal-title":"Ann Nutr Metab"},{"key":"R41-20260520","first-page":"1275","article-title":"Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice.","volume":"8","author":"Choi","year":"2018","journal-title":"Sci Rep"},{"key":"R42-20260520","first-page":"2661","article-title":"Overlapping mechanisms of action of brain-active bacteria and bacterial metabolites in the pathogenesis of common brain diseases.","volume":"14","author":"Eicher","year":"2022","journal-title":"Nutrients"},{"key":"R43-20260520","first-page":"1048","article-title":"Relationship between chronic constipation and brain-gut microflora axis.","volume":"24","author":"Chen","year":"2021","journal-title":"Zhonghua wei chang wai ke za zhi = Chin J Gastrointestinal Surg"},{"key":"R44-20260520","first-page":"1687","article-title":"Ulcerative colitis exacerbates lipopolysaccharide\u2010induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease.","volume":"114","author":"Villar\u00e1n","year":"2010","journal-title":"J Neurochem"},{"key":"R45-20260520","first-page":"1208","article-title":"Microbiota composition and metabolism are associated with gut function in Parkinson's disease.","volume":"35","author":"Cirstea","year":"2020","journal-title":"Mov Disord"},{"key":"R46-20260520","first-page":"e848","article-title":"Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson Disease.","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"R47-20260520","first-page":"1250","article-title":"The role of methane in intestinal diseases.","volume":"105","author":"Roccarina","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R48-20260520","first-page":"661","article-title":"Methanogen and human gut health--A review.","volume":"55","author":"Ge","year":"2015","journal-title":"Wei Sheng Wu Xue Bao"},{"key":"R49-20260520","first-page":"775","article-title":"Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American Consensus.","volume":"112","author":"Rezaie","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"R50-20260520","first-page":"1228","article-title":"Effects of methane on proximal colon motility of rats and ion channel mechanisms.","volume":"93","author":"Liu","year":"2013","journal-title":"nghua Yi Xue Za Zhi"},{"key":"R51-20260520","first-page":"805","article-title":"Methanogenic archaea in the human gastrointestinal tract.","volume":"19","author":"Hoegenauer","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R52-20260520","first-page":"105776","article-title":"The ever-changing roles of serotonin.","volume":"125","author":"Jones","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"key":"R53-20260520","first-page":"105314","article-title":"Reduced platelet 5-HT content is associated with rest tremor in Parkinson\u2019s disease.","volume":"108","author":"Wang","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"R54-20260520","first-page":"882","article-title":"Reduced plasma serotonin and 5-hydroxyindoleacetic acid levels in Parkinson\u2019s disease are associated with nonmotor symptoms.","volume":"21","author":"Tong","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"R55-20260520","first-page":"86","article-title":"Methane production during lactulose breath test is associated with gastrointestinal disease presentation.","volume":"48","author":"Pimentel","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R56-20260520","first-page":"1612","article-title":"Methane on breath testing is associated with constipation: a systematic review and meta-analysis.","volume":"56","author":"Kunkel","year":"2011","journal-title":"Dig Dis Sci"},{"key":"R57-20260520","first-page":"31","article-title":"Methanogens, methane and gastrointestinal motility.","volume":"20","author":"Triantafyllou","year":"2014","journal-title":"J Neurogastroenterol Motil"},{"key":"R58-20260520","first-page":"1415463","article-title":"The interplay between gut microbiota and the brain-gut axis in Parkinson\u2019s disease treatment.","volume":"15","author":"Jia","year":"2024","journal-title":"Front Neurol"},{"key":"R59-20260520","first-page":"179","article-title":"The gut microbiome in neurological disorders.","volume":"19","author":"Cryan","year":"2020","journal-title":"Lancet Neurol"},{"key":"R60-20260520","first-page":"e28032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease.","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"R61-20260520","first-page":"105803","article-title":"Modulating the biosynthesis and TLR4-interaction of lipopolysaccharide as an approach to counter gut dysbiosis and Parkinson\u2019s disease: role of phyto-compounds.","volume":"178","author":"Roy","year":"2024","journal-title":"Neurochem Int"},{"key":"R62-20260520","first-page":"861","article-title":"Transmissible \u03b1-synuclein seeding activity in brain and stomach of patients with Parkinson\u2019s disease.","volume":"141","author":"Thomzig","year":"2021","journal-title":"Acta Neuropathol (Berl)"},{"key":"R63-20260520","first-page":"1375","article-title":"More than constipation - bowel symptoms in Parkinson\u2019s disease and their connection to gut microbiota.","volume":"24","author":"Mertsalmi","year":"2017","journal-title":"Eur J Neurol"},{"key":"R64-20260520","first-page":"673708","article-title":"Partners in leaky gut syndrome: intestinal dysbiosis and autoimmunity.","volume":"12","author":"Kinashi","year":"2021","journal-title":"Front Immunol"},{"key":"R65-20260520","first-page":"105840","article-title":"The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders.","volume":"172","author":"Soca\u0142a","year":"2021","journal-title":"Pharmacol Res"},{"key":"R66-20260520","first-page":"930","article-title":"Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s Disease.","volume":"15","author":"Guo","year":"2023","journal-title":"Nutrients"},{"key":"R67-20260520","first-page":"226","article-title":"Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.","volume":"9","author":"Zhao","year":"2021","journal-title":"Microbiome"},{"key":"R68-20260520","first-page":"48","article-title":"Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway.","volume":"70","author":"Sun","year":"2018","journal-title":"Brain Behav Immun"},{"key":"R69-20260520","first-page":"e22035","article-title":"Fecal microbiota transplantation therapy for Parkinson\u2019s disease: a preliminary study.","volume":"99","author":"Xue","year":"2020","journal-title":"Medicine (Baltim)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045552","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:00:12Z","timestamp":1779274812000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":70,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045552","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-07-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}